Background: Patients with frequent premature ventricular complexes (PVCs) are at risk of developing reversible PVC-induced cardiomyopathy (rPVC-CMP). Not all determinants of rPVC-CMP are known.
Objective: To assess the impact of the QRS duration of PVCs on the development of rPVC-CMP.
Methods: In a consecutive series of 294 patients with frequent idiopathic PVCs referred for PVC ablation, the width of the PVC-QRS complex was assessed. The QRS width was correlated with the presence of rPVC-CMP.
Results: The PVC-QRS width was significantly greater in patients with rPVC-CMP than in patients without rPVC-CMP (164 ± 20 ms vs 149 ± 17 ms; P < .0001). The site of origin of the PVC had an impact on the PVC-QRS width, with epicardial PVCs having the broadest QRS complexes. Patients with PVCs originating from the right ventricular outflow tract or the fascicles had the narrowest QRS complexes. After adjusting for PVC burden, symptom duration, and PVC site of origin, PVC-QRS width and an epicardial PVC origin were independently associated with rPVC-CMP. Based on receiver operator characteristics analysis, a QRS duration of >150 ms best differentiated patients with and without rPVC-CMP (area under the curve 0.66; sensitivity 80%; specificity 52%). The PVC burden for developing rPVC-CMP is significantly lower in patients with a PVC-QRS width of ≥150 ms than in patients with a narrower PVC-QRS complex (22% ± 13% vs 28% ± 12%; P < .0001).
Conclusion: Broader PVCs and an epicardial PVC origin are associated with the development of rPVC-CMP independent of the PVC burden.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hrthm.2012.04.036 | DOI Listing |
J Electrocardiol
March 2022
Kartal Koşuyolu Heart Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey.
Background: The aim of the present study is to investigate the possible factors that might be predictive of effective antiarrhythmic effect of beta-blockers on premature ventricular complexes (PVC).
Methods: Data of 190 eligible consecutive patients to whom beta-blocker therapy had been initiated for treatment of PVC's were retrospectively evaluated. The Holter recording acquired before beta-blocker initiation and the first Holter acquired after beta blocker initiation during follow up was comprehensively evaluated for each patient.
Heart Rhythm
January 2021
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address:
Background: Frequent premature ventricular complexes (PVCs) can result in PVC-induced cardiomyopathy (PICM). Scarring has been described in patients with frequent PVCs in the absence of apparent heart disease and in patients with known cardiomyopathy.
Objective: The purpose of this study was to determine the impact of focal myocardial scarring as detected by cardiac magnetic resonance imaging (CMR) on PICM, procedural outcomes, and recovery of left ventricular function in patients with frequent PVCs.
Curr Cardiol Rep
September 2017
Division of Cardiovascular Medicine, University of Michigan Ann Arbor, Ann Arbor, MI, USA.
Purpose Of Review: The aim of this review is to describe predictors and therapeutic principles for PVC-induced cardiomyopathy.
Recent Findings: PVC-induced cardiomyopathy is a treatable condition resulting in a reversible form of cardiomyopathy. PVC-induced cardiomyopathy has only recently been recognized as an entity that causes a reversible form of cardiomyopathy.
Pacing Clin Electrophysiol
July 2016
Cardiology Department, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.
Very frequent premature ventricular complexes (PVCs) may be a reversible cause of dilated cardiomyopathy. Literature on this largely unrecognized entity has increased in the last 15 years. This paper reviews the literature on the consequences of frequent PVCs on myocardial function and management of PVC-associated cardiomyopathy.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
June 2016
Federation de Cardiologie, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris and INSERM U955, Créteil, France.
Introduction: Reversible premature ventricular complexes-induced cardiomyopathy (PVC-CMP) is a well-described, multi-factorial entity. Single predictors, such as PVC burden or QRS duration, may not apply equally to all patients in contemporary unselected populations including patients with structural heart disease (SHD) or with particular origin such as epicardial (EPI) PVC. We sought to evaluate clinical criteria associated with PVC-CMP notably focusing on the EPI origin impact and ECG recognition and the value of a new composite predictor of PVC-CMP, the PVC-CMP-Index.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!